From the Departments of Pathology (Drs Rogers, Carter, and Weinzierl; Mr Adams; and Mss Uwindatwa and Brawley), Pediatrics (Drs Rogers and Prahalad), and Care Transformation (Mr Cochran), Children's Healthcare of Atlanta, Atlanta, Georgia; and the Departments of Pathology (Drs Rogers, Carter, and Weinzierl) and Pediatrics (Drs Rogers and Prahalad; and Ms Bryan), Emory University School of Medicine, Atlanta, Georgia.
Arch Pathol Lab Med. 2019 Jan;143(1):115-121. doi: 10.5858/arpa.2017-0529-OA. Epub 2018 May 23.
CONTEXT.—: Disruption of outpatient laboratory services by routing the samples to commercial reference laboratories may seem like a cost-saving measure by the payers, but results in hidden costs in quality and resources to support this paradigm.
OBJECTIVE.—: To identify differences when outpatient tests are performed at the Children's Healthcare of Atlanta (Children's) Hospital lab compared to a commercial reference lab, and the financial costs to support the reference laboratory testing.
DESIGN.—: Outpatient testing was sent to 3 different laboratories specified by the payer. Orders were placed in the Children's electronic health record, blood samples were drawn by the Children's phlebotomists, samples were sent to the testing laboratory, and results appeared in the electronic health record. Data comparing the time to result, cancelled samples, and cost to sustain the system of ordering and reporting were drawn from multiple sources, both electronic and manual.
RESULTS.—: The median time from phlebotomy to result was 0.7 hours for testing at the Children's lab and 20.72 hours for the commercial lab. The median time from result posting to caregiver acknowledgment was 5.4 hours for the Children's lab and 18 hours for the commercial lab. The commercial lab cancelled 2.7% of the tests; the Children's lab cancelled 0.8%. The financial cost to support online ordering and reporting for testing performed at commercial labs was approximately $640,000 per year.
CONCLUSIONS.—: Tangible monetary costs, plus intangible costs related to delayed results, occur when the laboratory testing system is disrupted.
将门诊实验室服务的样本转至商业参考实验室,对于支付方来说,这似乎是一种节省成本的措施,但会导致质量和资源方面的隐性成本,从而难以维持这种模式。
确定在亚特兰大儿童保健中心(Children's)医院实验室进行门诊检测与在商业参考实验室进行检测之间的差异,以及支持参考实验室检测的财务成本。
门诊检测被送到支付方指定的 3 家不同的实验室。在 Children's 的电子健康记录中下达检测订单,由 Children's 的采血员采集血样,然后将样本送到检测实验室,检测结果会出现在电子健康记录中。从多个来源(包括电子和手动)提取比较检测结果时间、取消的样本以及维持订单和报告系统的成本的数据。
在 Children's 实验室进行检测时,从采血到出结果的中位数时间为 0.7 小时,而在商业实验室则为 20.72 小时。从出结果到护理人员确认的中位数时间在 Children's 实验室为 5.4 小时,在商业实验室为 18 小时。商业实验室取消了 2.7%的检测;而 Children's 实验室取消了 0.8%。支持商业实验室检测的在线订单和报告的财务成本约为每年 64 万美元。
当实验室检测系统受到干扰时,会产生有形的货币成本,以及与结果延迟相关的无形成本。